NIAID responds to CLF on antibiotic resistance testimony

The principal deputy director of the National Institute of Allergy and Infectious Diseases (NIAID), Dr. Hugh Auchincloss, notes “success against antimicrobial resistance will require a multifaceted approach that includes increased surveillance, more judicious use of antimicrobial drugs, and increased research on the biology of the microbes mechanisms of resistance, host responses, vaccines, diagnostics, and therapeutics.”

Dr. Auchincloss was responding to a letter sent to Anthony Fauci, MD, director, National Institute of Allergy and Infectious Diseases, by Keeve Nachman, PhD, MHS, and director of CLF’s Farming for the Future Program, and Robert Lawrence, MD, director, CLF. Nachman and Lawrence wrote to Fauci and Thomas Frieden, MD, MPH, director, Centers for Disease Control and Prevention, in June seeking to clarify Congressional testimony concerning the evidence against the use of antibiotics in industrial farm animal production.

In his response, Dr. Auchincloss wrote, “NIAID does find that the overall weight of evidence to date links antibiotic use in food animals with antibiotic resistance in humans.” Legislation on a bill to limit antibiotic use in food animal production, the Preservation of Antibiotics for Medical Treatment Act, is now pending in Congress.